1 Introduction to Research & Analysis Reports
1.1 Fetal Calf Serum Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fetal Calf Serum Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fetal Calf Serum Overall Market Size
2.1 Global Fetal Calf Serum Market Size: 2022 VS 2029
2.2 Global Fetal Calf Serum Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fetal Calf Serum Sales: 2018-2029
3 Company Landscape
3.1 Top Fetal Calf Serum Players in Global Market
3.2 Top Global Fetal Calf Serum Companies Ranked by Revenue
3.3 Global Fetal Calf Serum Revenue by Companies
3.4 Global Fetal Calf Serum Sales by Companies
3.5 Global Fetal Calf Serum Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fetal Calf Serum Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fetal Calf Serum Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fetal Calf Serum Players in Global Market
3.8.1 List of Global Tier 1 Fetal Calf Serum Companies
3.8.2 List of Global Tier 2 and Tier 3 Fetal Calf Serum Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fetal Calf Serum Market Size Markets, 2022 & 2029
4.1.2 North America-sourced
4.1.3 South America-sourced
4.1.4 Australia-sourced
4.1.5 Others
4.2 By Type – Global Fetal Calf Serum Revenue & Forecasts
4.2.1 By Type – Global Fetal Calf Serum Revenue, 2018-2023
4.2.2 By Type – Global Fetal Calf Serum Revenue, 2024-2029
4.2.3 By Type – Global Fetal Calf Serum Revenue Market Share, 2018-2029
4.3 By Type – Global Fetal Calf Serum Sales & Forecasts
4.3.1 By Type – Global Fetal Calf Serum Sales, 2018-2023
4.3.2 By Type – Global Fetal Calf Serum Sales, 2024-2029
4.3.3 By Type – Global Fetal Calf Serum Sales Market Share, 2018-2029
4.4 By Type – Global Fetal Calf Serum Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fetal Calf Serum Market Size, 2022 & 2029
5.1.2 Research & Development
5.1.3 Commercial Production
5.2 By Application – Global Fetal Calf Serum Revenue & Forecasts
5.2.1 By Application – Global Fetal Calf Serum Revenue, 2018-2023
5.2.2 By Application – Global Fetal Calf Serum Revenue, 2024-2029
5.2.3 By Application – Global Fetal Calf Serum Revenue Market Share, 2018-2029
5.3 By Application – Global Fetal Calf Serum Sales & Forecasts
5.3.1 By Application – Global Fetal Calf Serum Sales, 2018-2023
5.3.2 By Application – Global Fetal Calf Serum Sales, 2024-2029
5.3.3 By Application – Global Fetal Calf Serum Sales Market Share, 2018-2029
5.4 By Application – Global Fetal Calf Serum Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fetal Calf Serum Market Size, 2022 & 2029
6.2 By Region – Global Fetal Calf Serum Revenue & Forecasts
6.2.1 By Region – Global Fetal Calf Serum Revenue, 2018-2023
6.2.2 By Region – Global Fetal Calf Serum Revenue, 2024-2029
6.2.3 By Region – Global Fetal Calf Serum Revenue Market Share, 2018-2029
6.3 By Region – Global Fetal Calf Serum Sales & Forecasts
6.3.1 By Region – Global Fetal Calf Serum Sales, 2018-2023
6.3.2 By Region – Global Fetal Calf Serum Sales, 2024-2029
6.3.3 By Region – Global Fetal Calf Serum Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fetal Calf Serum Revenue, 2018-2029
6.4.2 By Country – North America Fetal Calf Serum Sales, 2018-2029
6.4.3 US Fetal Calf Serum Market Size, 2018-2029
6.4.4 Canada Fetal Calf Serum Market Size, 2018-2029
6.4.5 Mexico Fetal Calf Serum Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fetal Calf Serum Revenue, 2018-2029
6.5.2 By Country – Europe Fetal Calf Serum Sales, 2018-2029
6.5.3 Germany Fetal Calf Serum Market Size, 2018-2029
6.5.4 France Fetal Calf Serum Market Size, 2018-2029
6.5.5 U.K. Fetal Calf Serum Market Size, 2018-2029
6.5.6 Italy Fetal Calf Serum Market Size, 2018-2029
6.5.7 Russia Fetal Calf Serum Market Size, 2018-2029
6.5.8 Nordic Countries Fetal Calf Serum Market Size, 2018-2029
6.5.9 Benelux Fetal Calf Serum Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fetal Calf Serum Revenue, 2018-2029
6.6.2 By Region – Asia Fetal Calf Serum Sales, 2018-2029
6.6.3 China Fetal Calf Serum Market Size, 2018-2029
6.6.4 Japan Fetal Calf Serum Market Size, 2018-2029
6.6.5 South Korea Fetal Calf Serum Market Size, 2018-2029
6.6.6 Southeast Asia Fetal Calf Serum Market Size, 2018-2029
6.6.7 India Fetal Calf Serum Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fetal Calf Serum Revenue, 2018-2029
6.7.2 By Country – South America Fetal Calf Serum Sales, 2018-2029
6.7.3 Brazil Fetal Calf Serum Market Size, 2018-2029
6.7.4 Argentina Fetal Calf Serum Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fetal Calf Serum Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fetal Calf Serum Sales, 2018-2029
6.8.3 Turkey Fetal Calf Serum Market Size, 2018-2029
6.8.4 Israel Fetal Calf Serum Market Size, 2018-2029
6.8.5 Saudi Arabia Fetal Calf Serum Market Size, 2018-2029
6.8.6 UAE Fetal Calf Serum Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Fetal Calf Serum Major Product Offerings
7.1.4 Thermo Fisher Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Company Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Fetal Calf Serum Major Product Offerings
7.2.4 GE Healthcare Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.2.5 GE Healthcare Key News & Latest Developments
7.3 Sigma-Aldrich
7.3.1 Sigma-Aldrich Company Summary
7.3.2 Sigma-Aldrich Business Overview
7.3.3 Sigma-Aldrich Fetal Calf Serum Major Product Offerings
7.3.4 Sigma-Aldrich Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.3.5 Sigma-Aldrich Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Fetal Calf Serum Major Product Offerings
7.4.4 Merck Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Moregate BioTech
7.5.1 Moregate BioTech Company Summary
7.5.2 Moregate BioTech Business Overview
7.5.3 Moregate BioTech Fetal Calf Serum Major Product Offerings
7.5.4 Moregate BioTech Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.5.5 Moregate BioTech Key News & Latest Developments
7.6 Gemini
7.6.1 Gemini Company Summary
7.6.2 Gemini Business Overview
7.6.3 Gemini Fetal Calf Serum Major Product Offerings
7.6.4 Gemini Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.6.5 Gemini Key News & Latest Developments
7.7 Atlanta Biologicals
7.7.1 Atlanta Biologicals Company Summary
7.7.2 Atlanta Biologicals Business Overview
7.7.3 Atlanta Biologicals Fetal Calf Serum Major Product Offerings
7.7.4 Atlanta Biologicals Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.7.5 Atlanta Biologicals Key News & Latest Developments
7.8 Tissue Culture Biologicals
7.8.1 Tissue Culture Biologicals Company Summary
7.8.2 Tissue Culture Biologicals Business Overview
7.8.3 Tissue Culture Biologicals Fetal Calf Serum Major Product Offerings
7.8.4 Tissue Culture Biologicals Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.8.5 Tissue Culture Biologicals Key News & Latest Developments
7.9 Bovogen
7.9.1 Bovogen Company Summary
7.9.2 Bovogen Business Overview
7.9.3 Bovogen Fetal Calf Serum Major Product Offerings
7.9.4 Bovogen Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.9.5 Bovogen Key News & Latest Developments
7.10 Biowest
7.10.1 Biowest Company Summary
7.10.2 Biowest Business Overview
7.10.3 Biowest Fetal Calf Serum Major Product Offerings
7.10.4 Biowest Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.10.5 Biowest Key News & Latest Developments
7.11 Internegocios
7.11.1 Internegocios Company Summary
7.11.2 Internegocios Fetal Calf Serum Business Overview
7.11.3 Internegocios Fetal Calf Serum Major Product Offerings
7.11.4 Internegocios Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.11.5 Internegocios Key News & Latest Developments
7.12 RMBIO
7.12.1 RMBIO Company Summary
7.12.2 RMBIO Fetal Calf Serum Business Overview
7.12.3 RMBIO Fetal Calf Serum Major Product Offerings
7.12.4 RMBIO Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.12.5 RMBIO Key News & Latest Developments
7.13 Biological Industries
7.13.1 Biological Industries Company Summary
7.13.2 Biological Industries Fetal Calf Serum Business Overview
7.13.3 Biological Industries Fetal Calf Serum Major Product Offerings
7.13.4 Biological Industries Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.13.5 Biological Industries Key News & Latest Developments
7.14 PAN-Biotech
7.14.1 PAN-Biotech Company Summary
7.14.2 PAN-Biotech Business Overview
7.14.3 PAN-Biotech Fetal Calf Serum Major Product Offerings
7.14.4 PAN-Biotech Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.14.5 PAN-Biotech Key News & Latest Developments
7.15 VWR
7.15.1 VWR Company Summary
7.15.2 VWR Business Overview
7.15.3 VWR Fetal Calf Serum Major Product Offerings
7.15.4 VWR Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.15.5 VWR Key News & Latest Developments
7.16 Corning
7.16.1 Corning Company Summary
7.16.2 Corning Business Overview
7.16.3 Corning Fetal Calf Serum Major Product Offerings
7.16.4 Corning Fetal Calf Serum Sales and Revenue in Global (2018-2023)
7.16.5 Corning Key News & Latest Developments
8 Global Fetal Calf Serum Production Capacity, Analysis
8.1 Global Fetal Calf Serum Production Capacity, 2018-2029
8.2 Fetal Calf Serum Production Capacity of Key Manufacturers in Global Market
8.3 Global Fetal Calf Serum Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fetal Calf Serum Supply Chain Analysis
10.1 Fetal Calf Serum Industry Value Chain
10.2 Fetal Calf Serum Upstream Market
10.3 Fetal Calf Serum Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fetal Calf Serum Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のウシ胎児血清市場予測2023-2029：北米産、南米産、オーストラリア産、その他 |
| 【英語タイトル】Fetal Calf Serum Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5561 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：111 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のウシ胎児血清市場規模と予測を収録しています。・世界のウシ胎児血清市場：売上、2018年-2023年、2024年-2029年 ・世界のウシ胎児血清市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のウシ胎児血清市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「北米産」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ウシ胎児血清のグローバル主要企業は、Thermo Fisher、 GE Healthcare、 Sigma-Aldrich、 Merck、 Moregate BioTech、 Gemini、 Atlanta Biologicals、 Tissue Culture Biologicals、 Bovogen、 Biowest、 Internegocios、 RMBIO、 Biological Industries、 PAN-Biotech、 VWR、 Corningなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ウシ胎児血清のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のウシ胎児血清市場：タイプ別、2018年-2023年、2024年-2029年 世界のウシ胎児血清市場：タイプ別市場シェア、2022年 ・北米産、南米産、オーストラリア産、その他 世界のウシ胎児血清市場：用途別、2018年-2023年、2024年-2029年 世界のウシ胎児血清市場：用途別市場シェア、2022年 ・研究＆開発、量産化 世界のウシ胎児血清市場：地域・国別、2018年-2023年、2024年-2029年 世界のウシ胎児血清市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるウシ胎児血清のグローバル売上、2018年-2023年 ・主要企業におけるウシ胎児血清のグローバル売上シェア、2022年 ・主要企業におけるウシ胎児血清のグローバル販売量、2018年-2023年 ・主要企業におけるウシ胎児血清のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Thermo Fisher、 GE Healthcare、 Sigma-Aldrich、 Merck、 Moregate BioTech、 Gemini、 Atlanta Biologicals、 Tissue Culture Biologicals、 Bovogen、 Biowest、 Internegocios、 RMBIO、 Biological Industries、 PAN-Biotech、 VWR、 Corning ************************************************************* ・調査・分析レポートの概要 ウシ胎児血清市場の定義 市場セグメント 世界のウシ胎児血清市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のウシ胎児血清市場規模 世界のウシ胎児血清市場規模：2022年 VS 2029年 世界のウシ胎児血清市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのウシ胎児血清の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のウシ胎児血清製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：北米産、南米産、オーストラリア産、その他 ウシ胎児血清のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：研究＆開発、量産化 ウシ胎児血清の用途別グローバル売上・予測 ・地域別市場分析 地域別ウシ胎児血清市場規模 2022年と2029年 地域別ウシ胎児血清売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Thermo Fisher、 GE Healthcare、 Sigma-Aldrich、 Merck、 Moregate BioTech、 Gemini、 Atlanta Biologicals、 Tissue Culture Biologicals、 Bovogen、 Biowest、 Internegocios、 RMBIO、 Biological Industries、 PAN-Biotech、 VWR、 Corning ... |
Fetal Calf Serum is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells.
This report aims to provide a comprehensive presentation of the global market for Fetal Calf Serum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fetal Calf Serum. This report contains market size and forecasts of Fetal Calf Serum in global, including the following market information:
Global Fetal Calf Serum Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fetal Calf Serum Market Sales, 2018-2023, 2024-2029, (L)
Global top five Fetal Calf Serum companies in 2022 (%)
The global Fetal Calf Serum market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
North America-sourced Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fetal Calf Serum include Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fetal Calf Serum manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fetal Calf Serum Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Fetal Calf Serum Market Segment Percentages, by Type, 2022 (%)
North America-sourced
South America-sourced
Australia-sourced
Others
Global Fetal Calf Serum Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Fetal Calf Serum Market Segment Percentages, by Application, 2022 (%)
Research & Development
Commercial Production
Global Fetal Calf Serum Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Fetal Calf Serum Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fetal Calf Serum revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fetal Calf Serum revenues share in global market, 2022 (%)
Key companies Fetal Calf Serum sales in global market, 2018-2023 (Estimated), (L)
Key companies Fetal Calf Serum sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
GE Healthcare
Sigma-Aldrich
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
VWR
Corning
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fetal Calf Serum, market overview.
Chapter 2: Global Fetal Calf Serum market size in revenue and volume.
Chapter 3: Detailed analysis of Fetal Calf Serum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fetal Calf Serum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fetal Calf Serum capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のウシ胎児血清市場予測2023-2029：北米産、南米産、オーストラリア産、その他] (コード：MMG23JU5561)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のウシ胎児血清市場予測2023-2029：北米産、南米産、オーストラリア産、その他]についてメールでお問い合わせ |
